HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Liver transplantation in fulminant hepatic failure: experience with 40 adult patients over a 17-year period.

AbstractINTRODUCTION:
To evaluate the influence of pretransplantation recipient and donor prognostic factors on graft-patient survival.
MATERIALS AND METHODS:
Between April 1986 and June 2003, 40 liver transplantation (LT) procedures to treat fulminant hepatic failure were performed (5.7%). Twenty-one pre-LT recipient and donor variables were retrospectively considered for analysis.
RESULTS:
The indications for LT were hyperacute (62.5%), acute (35%), and subacute hepatic failure (2.5%). Glasgow Coma Scale scores ranged from <5 in 22 patients to > or =5 in 18 patients. The causes were hepatitis B (n = 21), unknown (n = 10), Amanita phalloides (n = 5), and other (n = 4). The 1-year graft and patient survival rates were 48.3% and 61.3%, respectively. Perioperative and late mortality was 27.5% and 22.5%. The only variable statistically significant for graft survival was waiting list time for LT <48 hours (P = .05).
DISCUSSION:
Liver transplantation is the best treatment for fulminant hepatic failure, with a 1-year patient survival rate of 61.3%. The short waiting list time has an important role in outcome.
AuthorsR Montalti, B Nardo, P Beltempo, R Bertelli, L Puviani, A Cavallari
JournalTransplantation proceedings (Transplant Proc) Vol. 37 Issue 2 Pg. 1085-7 (Mar 2005) ISSN: 0041-1345 [Print] United States
PMID15848630 (Publication Type: Journal Article)
Topics
  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Female
  • Follow-Up Studies
  • Glasgow Coma Scale
  • Graft Survival
  • Humans
  • Liver Failure, Acute (surgery)
  • Liver Transplantation (mortality, physiology)
  • Male
  • Middle Aged
  • Retrospective Studies
  • Survival Analysis
  • Time Factors
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: